Position in IMTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,146,964
-$795,893 QoQ
Shares Held
2,149,082
+2.8% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 99.26289457545128.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7371054245487143.ToString("F0")%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. IMTX ranks #92 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in IMTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,146,964 | 2,149,082 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,942,857 | 2,089,796 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $18,789,334 | 2,205,321 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $15,086,014 | 2,804,092 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $13,952,196 | 3,093,614 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,334,506 | 2,438,046 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,866,344 | 163,571 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,770,002 | 324,441 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,390,546 | 512,897 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,614,173 | 153,293 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,732,971 | 236,008 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,376,950 | 119,320 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,163,287 | 313,520 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,099,100 | 240,999 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,334,300 | 133,430 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $837,422 | 96,145 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $364,638 | 45,637 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $600,633 | 44,690 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $157,326 | 12,102 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $53,811 | 4,635 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $463,981 | 41,390 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,790 | 1,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $99,044 | 9,335 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||